Beneficial effects of the rho kinase inhibitor Y27632 in murine puromycin aminonucleoside nephrosis

Kidney and Blood Pressure Research

Volumn 31, Issue 2, 2008, Pages 111-121

  Wang, Liming ^a   Ellis, Mathew J ^a   Fields, Timothy A ^a   Howell, David N ^a   Spurney, Robert F ^a,b  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MSRB II   (United States)

Author keywords

Blood pressure; Glomerulonephritis; Rho GTPases; Rho kinase

Indexed keywords

4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; HYDRALAZINE; MEMBRANE PROTEIN; NEPHRIN; PROTEIN NEPH1; PUROMYCIN AMINONUCLEOSIDE; RHO KINASE;

ALBUMINURIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; HISTOPATHOLOGY; NEPHROSIS; NONHUMAN; PODOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEINURIA; RAT; SYSTOLIC BLOOD PRESSURE;

AMIDES; ANIMALS; ANTIHYPERTENSIVE AGENTS; CELLS, CULTURED; DISEASE MODELS, ANIMAL; EPITHELIAL CELLS; KIDNEY GLOMERULUS; MEMBRANE PROTEINS; MICE; NEPHROSIS; PODOCYTES; PUROMYCIN AMINONUCLEOSIDE; PYRIDINES; RHO-ASSOCIATED KINASES;

EID: 43049142649     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000121531     Document Type: Article

References (66)

1. Sharpe CC, Hendry BM: Signaling: focus on Rho in renal disease. J Am Soc Nephrol 2003;14:261-264.
2. Kanda T, Wakino S, Hayashi K, Homma K, Ozawa Y, Saruta T: Effect of fasudil on Rhokinase and nephropathy in subtotally nephrectomized spontaneously hypertensive rats. Kidney Int 2003;64:2009-2019.
3. Nagatoya K, Moriyama T, Kawada N, Takeji M, Oseto S, Murozono T, Ando A, Imai E, Hori M: Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney Int 2002;61:1684-1696.
4. Satoh S, Yamguchi T, Hitomi A, Sato N, Shiraiwa K, Ikegaki I Asano T, Shimokawa H: Fasudil attenuates interstitial fibrosis in rat kidneys with unilateral ureteral obstruction. Eur J Pharmacol 2002;455:169-174.
5. Sun GP, Kohno M, Guo P, Nagai Y, Miyata K, Fan YY, Kimura S, Kiyomoto H, Ohmori K, Li DT, Abe Y, Nishiyama A: Involvements of Rho-kinase and TGF-β pathways in aldosterone-induced renal injury. J Am Soc Nephrol 2006;17:2193-2201.
6. Nishikimi T, Matsuoka H: Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effect of Rho-kinase inhibitor in hypertensive glomerulosclerosis. J Pharmacol Sci 2006;100:22-28.
7. Teraishi K, Kurata H, Nakajima A, Takaoka M, Matsumura Y: Preventive effect of Y-27632, a selective Rho-kinase inhibitor, on ischemia/reperfusion- induced acute renal failure in rats. Eur J Pharmacol 2004;505:205-211.
8. Asanuma K, Yanagida-Asanuma E, Takagi M, Kodama F, Tomino Y: The role of podocytes in proteinuria. Nephrology (Carlton) 2007;12(Suppl 3):S15-S20.
9. Cavarape A, Endlich N, Assaloni R, Bartoli E, Steinhausen M, Parekh N: Rho-kinase inhibition blunts renal vasoconstriction induced by distinct signaling pathways in vivo. J Am Soc Nephrol 2003;13:37-45.
10. Uehata M, Ishizaki T, Staoh H, Ono T, Kawahara T, Morishita T, Tamakawa H, Yamagami K, Inui J, Maekawa M, Narumiya S: Calcium sensitization of smooth muscle mediated by Rho-associated protein kinase in hypertension. Nature 1997;389:990-994.
11. Takahara A, Sugiyama A, Satoh Y, Yoneyama M, Hashimoto K: Cardiovascular effects of Y-27632, a selective Rho-associated kinase inhibitor, assessed in the halothane-anesthetized canine model. Eur J Pharmacol 2003;460:51-57.
12. Amano M, Chihara K, Kimura K, Fukata Y, Nakamura N, Matsuura Y, Kaibuchi K: Formation of actin stress fibers and focal adhesions enhanced by Rho-kinase. Science 1997;275:1308-1311.
13. Seasholtz TM, Majumdatr M, Kaplan DD, Brown JH: Rho and Rho kinase mediate thrombin-stimulated vascular smooth muscle cell DNA synthesis and migration. Circ Res 1999;84:1186-1193.
14. Heusinger-Ribeiro J, Eberlein M, Wahab NA, Goppelt-Stuebe M: Expression of connective tissue growth factor in human renal fibroblasts: regulatory roles of RhoA and cAMP. J Am Soc Nephrol 2001;12:1853-1861.
15. Endlich N, Kress KR, Reiser J, Uttenweiler D, Kriz W, Mundel P, Endlich K: Podocytes respond to mechanical stress in vitro. J Am Soc Nephrol 2001;12:413-422.
16. Danesh FR, Sadeghi MM, Amro N, Philips C, Zeng L, Lin S, Sahai A, Kanwar YS: 3-hydroxy-3-methylglutaryl CoA reductase inhibitors prevent high glucose-induced proliferation of mesangial cells via modulation of Rho GTPase/p21 signaling pathways: implications for diabetic nephropathy. Proc Natl Acad Sci USA 2002;99:8301-8305.
17. Gao S, Li C, Shimokawa T, Terashita T, Matsuda S, Yaoita E, Kobayashi N: Rho-family small GTPases are involved in forskolin-induced cell-cell contact formation of renal glomerular podocytes in vitro. Cell Tissue Res 2007;328:391-400.
18. Gao S, Li C, Chen J, Lei P, Saito S, Terashita T, Saito K, Miyawaki K, Shigemoto K, Mominoki K, Matsuda S, Kobayashi N: Rho-ROCK signal pathway regulates microtubule-based process formation of cultured podocytes - inhibition of ROCK promoted process elongation. Exp Nephrol 2004;97:e49-e61.
19. Shibata S, Nagase M, Fujita T: Fluvastatin ameliorate podocyte injury in proteinuric rats via modulation of excessive Rho signaling. J Am Soc Nephrol 2006;17:754-764.
20. Yoshimura A, Inui K, Nemota T, Uda S, Sugenoya Y, Watanabe S, Yokota N, Taira T, Iwasaki S, Idura T: Simvastatin suppresses glomerular cell proliferation and macrophage infiltration in rats with mesangial proliferative nephritis. J Am Soc Nephrol 1998;9:2027-2039.
21. Wang L, Pazmino K, Fields T, Dai Q, Howell DN, Burchette JL, Coffman TM, Spurney RF: Activation of Gαq-coupled signaling pathways in glomerular podocytes promotes renal injury. J Am Soc Nephrol 2005;16:3611-3622.
22. Ishizaki T, Uehata M, Tamechika I, Keel J, Nonomura K, Maekawa M, Narumiya S: Pharmacological properties of Y-27632, a specific inhibitor of Rho-associated kinases. Mol Pharmacol 2000;57:976-983.
23. Kawachi H, Koike H, Kurihara H, Yaoita E, Orikasa M, Shia MA, Sakai T, Yamamoto T, Salant DJ, Shimizu F: Cloning of rat nephrin: expression in the developing glomeruli and in proteinuric states. Kidney Int 2000;57:1949-1961.
24. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
25. Ito M, Oliverio MI, Mannon PJ, Best CF, Maeda N, Smithies O, Coffman TM: Regulation of blood pressure by the type 1A angiotensin II receptor gene. Proc Natl Acad Sci USA 1995;92:3521-3525.
26. Flannery PJ, Spurney RF: Angiotensin II (ANG2)-dependent activation of extracellular signal-regulated kinase (ERK) is mediated by epidermal growth factor receptor (EGFR) transactivation in glomerular podocytes. Nephron 2006;103:109-118.
27. Reid T, Furuyashiki T, Ishizaki T, Watanabe G, Watanabe N, Fujisawa K, Morii N, Madaule P, Narumiya S: Rhotekin, a new putative target for Rho bearing homology to a serine/threonine kinase, PKN, and rhophilin in the Rho-binding domain. J Biol Chem 1996;271:13556-13560.
28. Menne J, Meier M, Pak JK, Boehne M, Kirsch T, Lindschau C, Ociepka R, Leitges M, Rinta-Valkama J, Holthofer H, Haller H: Nephrin loss in experimental diabetic nephropathy is prevented by deletion of protein kinase C alpha signaling in-vivo. Kidney Int 2006;70:1456-1462.
29. Benigni A, Zoja C, Tomasoni S, Campana M, Corna D, Zanchi C, Gagliardini E, Barofano E, Rottoli D, ItoT, Remuzzi G: Transcriptional regulation of nephrin gene by peroxisome proliferator-activated receptor-γ agonist: molecular mechanism of antiproteinuric effect of pioglitazone. J Am Soc Nephrol 2006;17:1624-1632.
30. Luimula P, Ahola H, Wang SX, Solin ML, Aaltonen P, Tikkanen NI, Kerjaschki D, Holthofer H: Nephrin in experimental glomerular disease. Kidney Int 2000;58:1461-1468.
31. Luimula P, Sandstrom N, Novikov D, Hothofer H: Podocyte-associated molecules in puromycin aminonucleoside nephrosis of the rat. Lab Invest 2002;82:713-718.
32. Benigni A, Tomasoni S, Gagliardini E, Zoja C, Grunkemeyer JA, Kalluri R, Remuzzi G: Blocking angiotensin II synthesis/activity preserves glomerular nephrin in rats with severe nephrosis. J Am Soc Nephrol 2001;12:941-948.
33. Cao Z, Bonnet F, Candido R, Nesteroff SP, Burns WC, Kawachi H, Shimizu F, Carey RM, Basparo MD, Cooper ME: Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury. J Am Soc Nephrol 2002;13:1773-1787.
34. Yuan H, Takeuchi E, Taylor GA, McLaughlin M, Brown D, Salant DJ: Nephrin dissociates from actin, and its expression is reduced in early experimental membranous nephropathy. J Am Soc Nephrol 2002;13:946-956.
35. Patrakka J, Ruotsalainen V, Ketola I, Holmberg C, Meikinheimo M, Tryggvason K, Jalankl H: Expression of nephrin in pediatric kidney diseases. J Am Soc Nephrol 2001;12:289-296.
36. Mao J, Zhang Y, Du L, Dai Y, Yang C, Liang L: Expression profile of nephrin, podocin, and CD2AP in Chinese children with MCNS and IgA nephropathy. Pediatr Nephrol 2006;21:1666-1675.
37. Schmid H, Henger A, Cohen CD, Frach K, Grone, H, Schlondorff D, Kretzler M: Gene expression profiles of podocyte-associated molecules as diagnostic markers in acquired proteinuric diseases. J Am Soc Nephrol 2003;14:2958-2966.
38. Ransom RF, Lam NG, Hallett MA, Atkinson SJ, Smoyer WE: Glucocorticoids protect and enhance recovery of cultured murine podocytes via actin filament stabilization. Kidney Int 2005;68:2473-2483.
39. Hamano Y, Grunkemeyer JA, Sudhakar A, Zeisberg M, Cosgrove D, Morello R, Lee B, Sugimoto H, Kalluri R: Determinants of vascular permeability in the kidney glomerulus. J Biol Chem 2002;277:31154-31162.
40. Putaala H, Soininen R, Kelpelainen P, Wartiovaara J, Tryggvason K: The murine nephrin gene is specifically expressed in kidney, brain and pancreas: inactivation of the gene leads to massive proteinuria and neonatal death. Hum Mol Genet 2001;10:1-8.
41. Rantanen M, Palmen T, Patari A, Ahola H, Lehtonen S, Astrom E, Floss T, Vauti F, Wurst W, Ruiz P, Kerjaschki D, Holthofer H: Nephrin TRAP mice lack slit diaphragms and show fibrotic glomeruli and cystic tubular lesions. J Am Soc Nephrol 2002;13:1586-1594.
42. Kestila M, Lenkkeri U, Mannikko M, Lamerdin J, McCready P, Putaala H, Ruotsalainen V, Morita T, Nissinen M, Herva R, Kashtan CE, Peltonen L, Holmberg C, Olsen A, Tryggvason K: Positionally cloned gene for a novel glomerular protein nephrin is mutated in congenital nephrotic syndrome. Mol Cell 1998;1:575-582.
43. Liu G, Kaw B, Kurfis J, Rahmanuddin S, Kanwar YS, Chugh SS: Neph 1 and nephrin interaction in the slit diaphragm is an important determinant of glomerular permeability. J Clin Invest 2003;112:209-221.
44. Shimizu Y, Dobashi K, Iizuka K, Horie T, Suzuki K, Tukagoshi H, Nakazawa T, Nadazato Y, Mori M: contributino of small GTPase Rho and its target protein ROCK in a murine model of lung fibrosis. Am J Resp Crit Care Med 2001;162:210-217.
45. Jones N, Blasutig IM, Eremina V, Shino A, Kawamura M, Ohtsuki K, Ohkawa S, Nishikawa K, Fujiwara Y: Nck adapter protein link nephrin to the actin cytoskeleton of kidney podocytes. Nature 2006;440:818-823.
46. Verma R, Kovari I, Soofi A, Nihalani D, Patrie K, Holzman LB: Nephrin ectodomain engagement results in Src kinase activation, nephrin phosphorylation, Nck recruitment, and actin polymerization. J Clin Invest 2006;116:1346-1359.
47. Verma R, Wharram B, Kovari I, Kunkel R, Nihalani D, Wary KK, Wiggins RC, Killen P, Holzman LB: Fyn binds to and phosphorylates the kidney slit diaphragm component nephrin. J Biol Chem 2003;278:20716-20723.
48. Quack I, Rump LC, Gerke P, Salther I, Vinke T, Vonend O, Grunwald T, Sellin L: β-arrestin mediates nephrin endocytosis and impairs slit diaphragm integrity. Proc Natl Acad Sci USA 2006;103:14110-14115.
49. Donoviel D, Freed D, Vogel H, Potter DG, Hawkins E, Barrish JP, Mathur BN, Turner A, Geske R, Montgomery CA, Starbuck M, Brandt M, Gupta A, Ramirez-Solis R, Zambrowicz BP, Powell DR: Proteinuria and perinatal lethality in mice lacking NEPH1, a novel protein with homology to NEPHRIN. Mol Cell Biol 2001;21:4829-4836.
50. Ruotsalainen V, Ljungberg P, Wartiovaara J, Lenkkeri U, Kestila M, Jalanko H, Holmberg C, Tryggvason K: Nephrin is specifically located at the slit diaphragm of glomerular podocytes. Proc Natl Acad Sci USA 1999;96:7962-7967.
51. Barletta GM, Kovari IA, Verma RK, Kerjaschki D, Holzman LB: Nephrin and Neph1 co-localize at the podocyte foot process intercellular junction and form cis-heterooligomers. J Biol Chem 2003;278:19266-19271.
52. Gerke P, Huber TB, Sellin L, Benzing T, Walz G: Homodimerization and heterodimerization of the glomerular podocyte proteins nephrin and Neph1. J Am Soc Nephrol 2003;14:918-926.
53. Kobayashi N, Nakano S, Mita SI, Kobayashi T, Honda T, Tsubokou Y, Matsuoka H: Involvement of Rho-kinase pathway for angiotensin II-induced plasminogen activator inhibitor-1 gene expression and cardiovascular remodeling in hypertensive rats. J Pharmacol Exp Ther 2002;301:459-466.
54. Yayama K, Kawao M, Tujii H, Itoh N, Okamoto H: Dup753 prevents the development of puromycin aminonucleoside-induced nephrosis. Eur J Pharmacol 1993;236:337-348.
55. B. Am J Physiol 2004;287:C1209-C1218.
56. Martin C, Goggel R, Ressmeyer AR, Uhlig S: Pressor responses to platelet-activating factor and thromboxane are mediated by Rho kinase. Am J Physiol 2004;287:L250-L257.
57. Saeguse S, Tsubone H, Kuwahara M: Leukotriene D4-induced Rho-mediated actin reorganization in human bronchial smooth muscle cells. Eur J Pharmacol 2001;413:163-171.
58. Stork JE, Rahman MA, Dunn MJ: Eicosanoids in experimental human renal disease. Am J Med 1986;80:34-45.
59. Lopez-Novoa J: Potential role of platelet activating factor in acute renal failure. Kidney Int 1999;55:1672-1682.
60. Clarkson MR, McGinty A, Godson C, Brady HR: Leukotrienes and lipoxins: lipoxygenase-derived modulators of leukocyte recruitment and vascular tone in glomerulonephritis. Nephol Dial Transplant 1998;13:3043-3051.
61. Sanderberg KJH: Kidney angiotensin receptors and their role in renal pathophysiology. Semin Nephrol 2000;20:402-416.
62. Kohan DE: Endothelins in the kidney: physiology and pathophysiology. Am J Kidney Dis 1993;22:493-510.
63. Shibouta Y, Terashita ZI, Imura Y, Shino A, Kawamura M, Ohtsuki K, Ohkawa S, Nishikawa K, Fujiwara Y: Involvement of thromboxane A2, leukotrienes and free radicals in puromycin nephrosis in rats. Kidney Int 1991;39:920-929.
64. Fu P, Liu F, Su S, Wang W, Huang XR, Entman ML, Schwartz RJ, Wei L, Lan HY: Signaling mechanism of renal fibrosis in unilateral ureteral obstructive kidney disease in ROCK1 knockout mice. J Am Soc Nephrol 2006;17:3105-3114.
65. Mundel P, Reiser J, Kriz W: Induction of differentiation in cultured rat and human podocytes. J Am Soc Nephrol 1997;8:697-705.
66. Saleem MA, O'Hare MJ, Reiser J, Coward RJ, Inward CD, Farren T, Xing CY, Ni L, Mathieson PW, Mundel P: A conditionally immortalized human podocyte cell line demonstrating nephrin and podocin expression. J Am Soc Nephrol 2002;13:630-638.